Literature DB >> 2570837

Human liver and plasma aspirin esterase.

F M Williams1, E M Mutch, E Nicholson, H Wynne, P Wright, D Lambert, M D Rawlins.   

Abstract

The plasma, in addition to the liver, is a major site of hydrolysis of aspirin. Human plasma and liver aspirin esterase activities in samples from a group of patients varied over a two fold range and there was a significant correlation between individual plasma and liver activities. Human liver aspirin esterase was present in the cytosolic and microsomal fractions. Cytosolic and microsomal enzymes had different activities and apparent affinities for aspirin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2570837     DOI: 10.1111/j.2042-7158.1989.tb06487.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  10 in total

1.  Paraoxonase 1 (PON1) modulates the toxicity of mixed organophosphorus compounds.

Authors:  Karen L Jansen; Toby B Cole; Sarah S Park; Clement E Furlong; Lucio G Costa
Journal:  Toxicol Appl Pharmacol       Date:  2009-02-09       Impact factor: 4.219

2.  Aspirin as a COX inhibitor and anti-inflammatory drug in human skeletal muscle.

Authors:  Stephen M Ratchford; Kaleen M Lavin; Ryan K Perkins; Bozena Jemiolo; Scott W Trappe; Todd A Trappe
Journal:  J Appl Physiol (1985)       Date:  2017-07-13

3.  Benorylate hydrolysis by human plasma and human liver.

Authors:  F M Williams; U Moore; R A Seymour; E M Mutch; E Nicholson; P Wright; H Wynne; P G Blain; M D Rawlins
Journal:  Br J Clin Pharmacol       Date:  1989-12       Impact factor: 4.335

Review 4.  The toxicity of mixtures of specific organophosphate compounds is modulated by paraoxonase 1 status.

Authors:  Toby B Cole; Karen Jansen; Sarah Park; Wan-Fen Li; Clement E Furlong; Lucio G Costa
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

Review 5.  Age-related changes in hepatic function. Implications for drug therapy.

Authors:  K Woodhouse; H A Wynne
Journal:  Drugs Aging       Date:  1992 May-Jun       Impact factor: 3.923

6.  Plasma esterases and inflammation in ageing and frailty.

Authors:  Ruth E Hubbard; M Sinead O'Mahony; Brian L Calver; Ken W Woodhouse
Journal:  Eur J Clin Pharmacol       Date:  2008-05-28       Impact factor: 2.953

7.  Pharmacokinetics and pharmacodynamics in copper deficiency. I. Antiinflammatory activity of aspirin.

Authors:  A Lopez-Anaya; C Dawson; C Gonzales; M Bacolod; V Kishore
Journal:  Biol Trace Elem Res       Date:  1994-02       Impact factor: 3.738

8.  Effects of Panax Notoginseng Saponins on Esterases Responsible for Aspirin Hydrolysis In Vitro.

Authors:  Zongxi Sun; Yali Wu; Song Liu; Shaonan Hu; Bo Zhao; Pengyue Li; Shouying Du
Journal:  Int J Mol Sci       Date:  2018-10-12       Impact factor: 5.923

9.  Inhibitory Influence of Panax notoginseng Saponins on Aspirin Hydrolysis in Human Intestinal Caco-2 Cells.

Authors:  Zongxi Sun; Yali Wu; Bing Yang; Baochen Zhu; Shaonan Hu; Yang Lu; Bo Zhao; Shouying Du
Journal:  Molecules       Date:  2018-02-18       Impact factor: 4.411

Review 10.  Do Aspirin and Flavonoids Prevent Cancer through a Common Mechanism Involving Hydroxybenzoic Acids?-The Metabolite Hypothesis.

Authors:  Ranjini Sankaranarayanan; D Ramesh Kumar; Janki Patel; G Jayarama Bhat
Journal:  Molecules       Date:  2020-05-10       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.